Antimicrobial Susceptibility of beta-emolytic Streptococci Isolated during the Period of 1999.
- Author:
Jongsun PARK
1
;
Young UH
;
Gyu Yul HWANG
;
In Ho JANG
;
Kap Jun YOON
Author Information
1. Department of Clinical Pathology, Yonsei University Wonju College of Medicine, Wonju, Korea. u931018@wonju.yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
beta-emolytic streptococci;
Antimicrobial susceptibility test;
Erythromycin resistance;
Clindamycin resistance
- MeSH:
Agar;
Ceftriaxone;
Chloramphenicol;
Clindamycin;
Drug Resistance, Microbial;
Erythromycin;
Gangwon-do;
Humans;
Penicillins;
Streptococcal Infections;
Tetracycline;
Vaccines;
Vancomycin
- From:Korean Journal of Clinical Pathology
2000;20(5):475-479
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Erythromycin is currently recommended as an alternative antibiotic for treatment of streptococcal infections in patients allergic to penicillins. Less than 5% of the group A streptococci are known as resistant to erythromycin but the resistance pattern differs among time and region. The purpose of this study was to determine the antimicrobial susceptibility of beta-emolytic streptococcal strains isolated during 1999 in Wonju. METHODS: A total of 107 beta-emolytic streptococci were isolates from the Wonju Christian Hospital during 1999. The susceptibility to penicillin, erythromycin, tetracycline, vancomycin, ceftriaxone, chloramphenicol, and clindamycin was tested with agar dilution method. RESULTS: No beta-emolytic streptococci strain was resistant to penicillin, ceftriaxone and vancomycin. Among beta-emolytic streptococci strains, 20-1%, 18-0% and 14-7% were resistant to tetracycline, erythromycin and clindamycin, respectively. CONCLUSIONS: It appears prudent that active surveillance of the beta-emolytic streptococci for antibiotic resistance be implemented since there are no currently effective vaccines or other methods for controlling the spread of infections due to these virulent organisms.
